middle.news
Telix Advances Brain Cancer Imaging with European Filing for TLX101-Px
8:28am on Wednesday 18th of February, 2026 AEDT
•
Healthcare
Read Story
Telix Advances Brain Cancer Imaging with European Filing for TLX101-Px
8:28am on Wednesday 18th of February, 2026 AEDT
Key Points
Submission of European marketing authorization application for TLX101-Px
TLX101-Px targets glioma brain cancer imaging using PET technology
Filing aligns with ongoing U.S. FDA regulatory efforts
Addresses critical unmet need for consistent glioma imaging in Europe
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TELIX PHARMACEUTICALS (ASX:TLX)
OPEN ARTICLE